Use Options For a Chance To Buy FOLD at a 33% Discount

Looking back to 43 days ago, Amicus Therapeutics Inc (FOLD) priced a 13,850,000 share secondary stock offering at $6.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday, the stock is now 25.7% higher than the offering price.

Investors who did not participate in the offering but would be a buyer of FOLD at a cheaper price, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July 2015 put at the $6 strike, which has a bid at the time of this writing of 50 cents. That would result in a cost basis of $5.50 per share before broker commissions in the scenario where the contract is exercised. If the contract is never exercised, the put seller would still keep the premium, which represents a 8.3% return against the $6.00 purchase commitment, or a 15.4% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

START SLIDESHOW:
Top YieldBoost Puts of of Stocks with Recent Secondaries »

Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. That can also introduce near-term volatility which improves the premiums a put seller can achieve. Selling a put does not give an investor access to FOLD's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. The chart below shows the one year performance of FOLD shares, versus its 200 day moving average:

Amicus Therapeutics Inc Chart

Looking at the chart above, FOLD's low point in its 52 week range is $1.77 per share, with $8.79 as the 52 week high point — that compares with a last trade of $8.23.

According to the ETF Finder at ETF Channel, FOLD makes up 1.15% of the SPDR S&P Biotech ETF ( XBI) which is trading up by about 1.4% on the day Wednesday.

More from Stocks

Video: Jim Cramer on What Trade Tariffs and Rising Rates Mean for Stocks

Video: Jim Cramer on What Trade Tariffs and Rising Rates Mean for Stocks

Dow Makes Move Higher as Bond Yields Hover Near 3% Threshold

Dow Makes Move Higher as Bond Yields Hover Near 3% Threshold

The Stock Market Isn't Rigged, Just Look At The Odds (VIDEO)

The Stock Market Isn't Rigged, Just Look At The Odds (VIDEO)

Kanye West Loves His Tesla - But Should He Love the Company's Stock, Too?

Kanye West Loves His Tesla - But Should He Love the Company's Stock, Too?

Should You Invest In DowDuPont Now?

Should You Invest In DowDuPont Now?